COVID-19 -- Worldwide/Unknown
"Background: The newly described SARS-CoV-2 lineage C.37 was recently classified as a variant of interest by the WHO (Lambda variant) based on its high circulation rates in South American countries and the presence of critical mutations in the spike protein. The impact of such mutations in infectivity and immune escape from neutralizing antibodies are entirely unknown.
"Methods: We performed a pseudotyped virus neutralization assay and determined the impact of the Lambda variant on
Read more about it at HealthMap Global Disease Alerts via http://healthmap.org/ln.php?8495092&promed&0
No comments:
Post a Comment